ANCHEN PHARMS FDA Approval ANDA 201442

ANDA 201442

ANCHEN PHARMS

FDA Drug Application

Application #201442

Application Sponsors

ANDA 201442ANCHEN PHARMS

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORAL8MCG0LUBIPROSTONELUBIPROSTONE
002CAPSULE;ORAL24MCG0LUBIPROSTONELUBIPROSTONE

FDA Submissions

UNKNOWN; ORIG1AP2022-06-27

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ANCHEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201442
            [companyName] => ANCHEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LUBIPROSTONE","activeIngredients":"LUBIPROSTONE","strength":"8MCG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LUBIPROSTONE","activeIngredients":"LUBIPROSTONE","strength":"24MCG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/27\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-27
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.